Andere Sprachen Ovid Therapeutics Inc.

Aktien

A2DQ8S

US6904691010

OVID

Verzögert Nasdaq Andere Börsenplätze 22:00:00 24.04.2024			% 5 Tage	% 1. Jan.
3,15 ^USD	-1,56 %		+1,29 %	-2,17 %

08.03.	Ovid Therapeutics Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
08.03.	Ovid Therapeutics Inc. meldet Ergebniszahlen für das vierte Quartal bis zum 31. Dezember 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference	04.04.
Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus Post Grant Review	28.03.
Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08.03.
Ovid Therapeutics : Corporate Presentation	08.03.
Earnings Flash (OVID) OVID THERAPEUTICS Reports Q4 Revenue $141,562	08.03.
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results	08.03.
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results	08.03.
Ovid Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	08.03.
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference	28.02.
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference	28.02.
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	06.02.
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	06.02.
Ovid Therapeutics Inc.(NasdaqGS:OVID) added to NASDAQ Biotechnology Index	18.12.
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting	04.12.
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)	01.12.
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)	01.12.
Ovid Therapeutics : Corporate Presentation	03.11.
Ovid Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03.11.
Earnings Flash (OVID) OVID THERAPEUTICS Reports Q3 Revenue $108,972	03.11.
Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates	03.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ovid Therapeutics Inc.

Aktien

A2DQ8S

US6904691010

OVID

Andere Sprachen

Filter